PD‐(L)1 has emerged as a research hotspot in recent years.[24] In HCC, PD‐L1 is predominantly manifested in neoplastic cells and specific immune‐suppressive cells, notably myeloid‐derived suppressor cells (MDSCs) and tumor‐associated macrophages (TAMs). The gene discussed is CD274; the disease is hepatocellular carcinoma.